Scilex CEO to Focus on Semnur’s SP-102 for Sciatica Treatment
Semnur Pharmaceuticals, a majority-owned subsidiary of Scilex Holding Company, has secured a $20 million private placement to fund the...
Jon Napitupulu
Krystal Biotech Focuses on Inhaled KB707 for Non-Small Cell Lung Cancer
Krystal Biotech has prioritized the inhaled formulation of KB707, its redosable gene therapy for solid tumors, based on early...
InnoCare Doses First Patient in Mesutoclax BCL2 Inhibitor Trial for MCL in China
InnoCare Pharma has dosed the first patient in a registrational trial of its BCL2 inhibitor, mesutoclax (ICP-248), for mantle...
Global Knee Replacement Surgery Market to Surpass $16B by 2030
The global knee replacement surgery market is projected to reach $16.17 billion by 2030, expanding at a 6.1% compound...
Septerna Doses First Participants in Sep-631 Phase 1 Trial
Septerna has dosed the first participants in a Phase 1 trial of SEP-631, an oral, selective, small molecule Mas-related...
Evoke Pharma Gimoti Patent Listed in FDA Orange Book
Evoke Pharma has secured a new U.S. patent (No. 12,377,064) for the use of its GIMOTI (metoclopramide) nasal spray...
Chinese Team Enables 24 Type 1 Diabetics to Stop Insulin
A Shenzhen-based medical team reports that 24 patients with Type 1 diabetes (T1DM) have discontinued insulin therapy following treatment...
Chinese Team Enables 24 Patients to Stop Insulin Use: Breakthrough in Type 1 Diabetes Treatment
A Shenzhen-based medical team reports that 24 patients with Type 1 diabetes (T1DM) have discontinued insulin therapy, achieving a...
Nurexone Biologic Shows Preclinical Spinal Cord Repair with Exopten
NurExone Biologic Inc. has released new preclinical MRI-DTI (Diffusion Tensor Imaging) data for ExoPTEN, its exosome-based therapy for spinal...
Hutchmed Completes Patient Enrollment for Orpathys®-Tagrisso® Lung Cancer Trial in China
Hutchmed has completed enrollment in its China Phase 3 SANOVO trial, evaluating the combination of savolitinib (Orpathys) and osimertinib...